Literature DB >> 19786843

The role of the prion protein membrane anchor in prion infection.

Suzette A Priola1, Kristin L McNally.   

Abstract

Normal cellular and abnormal disease-associated forms of prion protein (PrP) contain a C-terminal glycophosphatidyl-inositol (GPI) membrane anchor. The importance of the GPI membrane anchor in prion diseases is unclear but there are data to suggest that it both is and is not required for abnormal prion protein formation and prion infection. Utilizing an in vitro model of prion infection we have recently demonstrated that, while the GPI anchor is not essential for the formation of abnormal prion protein in a cell, it is necessary for the establishment of persistent prion infection. In combination with previously published data, our results suggest that GPI anchored PrP is important in the amplification and spread of prion infectivity from cell to cell.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786843      PMCID: PMC2802777          DOI: 10.4161/pri.3.3.9771

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  42 in total

Review 1.  Peripheral pathogenesis of prion diseases.

Authors:  M Glatzel; A Aguzzi
Journal:  Microbes Infect       Date:  2000-05       Impact factor: 2.700

2.  Molecular basis of scrapie strain glycoform variation.

Authors:  Ina Vorberg; Suzette A Priola
Journal:  J Biol Chem       Date:  2002-07-23       Impact factor: 5.157

3.  Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: role of prion protein expression in peripheral nerves and spleen.

Authors:  R Race; M Oldstone; B Chesebro
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Disease associated prion protein may deposit in the peripheral nervous system in human transmissible spongiform encephalopathies.

Authors:  J A Hainfellner; H Budka
Journal:  Acta Neuropathol       Date:  1999-11       Impact factor: 17.088

5.  Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes.

Authors:  Gerald S Baron; Kathy Wehrly; David W Dorward; Bruce Chesebro; Byron Caughey
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

6.  Transfer of scrapie prion infectivity by cell contact in culture.

Authors:  Nnennaya Kanu; Yutaka Imokawa; David N Drechsel; R Anthony Williamson; Christopher R Birkett; Christopher J Bostock; Jeremy P Brockes
Journal:  Curr Biol       Date:  2002-04-02       Impact factor: 10.834

7.  Uptake and neuritic transport of scrapie prion protein coincident with infection of neuronal cells.

Authors:  Ana Cristina Magalhães; Gerald S Baron; Kil Sun Lee; Olivia Steele-Mortimer; David Dorward; Marco A M Prado; Byron Caughey
Journal:  J Neurosci       Date:  2005-05-25       Impact factor: 6.167

8.  PrP(C) expression in the peripheral nervous system is a determinant of prion neuroinvasion.

Authors:  Markus Glatzel; Adriano Aguzzi
Journal:  J Gen Virol       Date:  2000-11       Impact factor: 3.891

9.  PrP expression and replication by Schwann cells: implications in prion spreading.

Authors:  Jérôme Follet; Catherine Lemaire-Vieille; Françoise Blanquet-Grossard; Valérie Podevin-Dimster; Sylvain Lehmann; Jean-Paul Chauvin; Jean-Pierre Decavel; Ruth Varea; Jacques Grassi; Michel Fontès; Jean-Yves Cesbron
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

10.  Identification of an intracellular site of prion conversion.

Authors:  Zrinka Marijanovic; Anna Caputo; Vincenza Campana; Chiara Zurzolo
Journal:  PLoS Pathog       Date:  2009-05-08       Impact factor: 6.823

View more
  15 in total

1.  Native nanodiscs formed by styrene maleic acid copolymer derivatives help recover infectious prion multimers bound to brain-derived lipids.

Authors:  Mansoore Esmaili; Brian P Tancowny; Xiongyao Wang; Audric Moses; Leonardo M Cortez; Valerie L Sim; Holger Wille; Michael Overduin
Journal:  J Biol Chem       Date:  2020-05-01       Impact factor: 5.157

2.  Shedding light on prion disease.

Authors:  Markus Glatzel; Luise Linsenmeier; Frank Dohler; Susanne Krasemann; Berta Puig; Hermann C Altmeppen
Journal:  Prion       Date:  2015       Impact factor: 3.931

3.  Increased infectivity of anchorless mouse scrapie prions in transgenic mice overexpressing human prion protein.

Authors:  Brent Race; Katie Phillips; Kimberly Meade-White; James Striebel; Bruce Chesebro
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

4.  A C-terminal membrane anchor affects the interactions of prion proteins with lipid membranes.

Authors:  Nam K Chu; Waheed Shabbir; Erin Bove-Fenderson; Can Araman; Rosa Lemmens-Gruber; David A Harris; Christian F W Becker
Journal:  J Biol Chem       Date:  2014-09-12       Impact factor: 5.157

5.  Prion 2016 Poster Abstracts.

Authors: 
Journal:  Prion       Date:  2016       Impact factor: 3.931

6.  Endogenous Brain Lipids Inhibit Prion Amyloid Formation In Vitro.

Authors:  Clare E Hoover; Kristen A Davenport; Davin M Henderson; Mark D Zabel; Edward A Hoover
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

Review 7.  Cell biology of prion strains in vivo and in vitro.

Authors:  Daniel Shoup; Suzette A Priola
Journal:  Cell Tissue Res       Date:  2022-02-02       Impact factor: 5.249

8.  Propagation of RML prions in mice expressing PrP devoid of GPI anchor leads to formation of a novel, stable prion strain.

Authors:  Sukhvir Paul Mahal; Joseph Jablonski; Irena Suponitsky-Kroyter; Anja Maria Oelschlegel; Maria Eugenia Herva; Michael Oldstone; Charles Weissmann
Journal:  PLoS Pathog       Date:  2012-06-07       Impact factor: 6.823

9.  Liberation of GPI-anchored prion from phospholipids accelerates amyloidogenic conversion.

Authors:  Shen-Jie Lin; Kun-Hua Yu; Jhih-Ru Wu; Chin-Fa Lee; Cheng-Ping Jheng; Hau-Ren Chen; Cheng-I Lee
Journal:  Int J Mol Sci       Date:  2013-09-03       Impact factor: 5.923

10.  Neurotoxicity of prion peptides mimicking the central domain of the cellular prion protein.

Authors:  Silvia Vilches; Cristina Vergara; Oriol Nicolás; Gloria Sanclimens; Sandra Merino; Sonia Varón; Gerardo A Acosta; Fernando Albericio; Miriam Royo; José A Del Río; Rosalina Gavín
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.